CIRCULATING KIDNEY INJURY MARKERS AND INTERLEUKIN-10 IDENTIFY NON-CRITICALLY ILL COVID-19 PATIENTS AT RISK OF DEATH

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

CIRCULATING KIDNEY INJURY MARKERS AND INTERLEUKIN-10 IDENTIFY NON-CRITICALLY ILL COVID-19 PATIENTS AT RISK OF DEATH

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Olivia Lenoir olivia.lenoir@inserm.fr Inserm, Université Paris Cité Paris Cardiovascular Research Centre Paris France -

Co-author 2

Florence Morin flrncmorin@gmail.com Assistance Publique-Hôpitaux de Paris Immunology and histocompatibility Lab, Saint-Louis Hospital Paris France -

Co-author 3

Léa Resmini lea.resmin@wanadoo.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 4

Mohamad Zaidan mohamad.zaidan@aphp.fr Assistance Publique-Hôpitaux de Paris Department of Nephrology Le Kremlin-Bicêtre France -

Co-author 5

Nassim Mahtal nassim.mahtal@pasteur.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 6

Sophie Ferlicot sophie.ferlicot@aphp.fr Assistance Publique-Hôpitaux de Paris Department of Pathology Le Kremlin-Bicêtre France -

Co-author 7

Victor G Puelles vgpuelles@gmail.com University Medical Center Hamburg-Eppendorf Hamburg Center for Kidney Health (HCKH) Hamburg Germany -

Co-author 8

Nicola Wanner n.wanner@uke.de University Medical Center Hamburg-Eppendorf Hamburg Center for Kidney Health (HCKH) Hamburg Germany -

Co-author 9

Julien Dang julien.dang@inserm.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 10

Thibaut d’Izarny-Gargas thibaut.dizarnygargas@aphp.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 11

Xavier Mariette xavier.mariette@aphp.fr Inserm Center for Immunology of Viral Infections and Autoimmune Diseases Le Kremlin-Bicêtre France -

Co-author 12

Olivier Hermine ohermine@gmail.com Assistance Publique-Hôpitaux de Paris Department of Clinical Hematology Paris France -

Co-author 13

Matthieu Resche-Rigon matthieu.resche-rigon@u-paris.fr Université Paris Cité Service de Biostatistique et Informatique Médicale (SBIM) Paris France -

Co-author 14

Pierre-Louis Tharaux pierre-louis.tharaux@inserm.fr Inserm, Université Paris Cité Paris Cardiovascular Research Centre Paris France *

Co-author 15